Business Description
![Moderna Inc Moderna Inc logo](https://static.gurufocus.com/logos/0C0000BJB3.png?14)
Moderna Inc
NAICS : 325412
SIC : 2836
ISIN : US60770K1079
Compare
Compare
Traded in other countries / regions
MRNA.USAM1RN34.Brazil0A45.UK0QF.Germany1MRNA.ItalyMRNA.MexicoMRNA.AustriaMRNA.Peru0QF.BulgariaMRNA_KZ.Kazakhstan IPO Date
2021-07-12Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.89 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.06 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 190.8 | |||||
3-Year EBITDA Growth Rate | -64.8 | |||||
3-Year EPS without NRI Growth Rate | -83.9 | |||||
3-Year Book Growth Rate | 78.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 42.82 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.15 | |||||
9-Day RSI | 40.78 | |||||
14-Day RSI | 40.17 | |||||
6-1 Month Momentum % | 35.16 | |||||
12-1 Month Momentum % | 22.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.03 | |||||
Quick Ratio | 3.91 | |||||
Cash Ratio | 3.58 | |||||
Days Inventory | 44.4 | |||||
Days Sales Outstanding | 60.89 | |||||
Days Payable | 34.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.4 | |||||
Shareholder Yield % | 1 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.37 | |||||
Operating Margin % | -101.1 | |||||
Net Margin % | -117.41 | |||||
FCF Margin % | -72.62 | |||||
ROE % | -39.3 | |||||
ROA % | -29.66 | |||||
ROIC % | -58.09 | |||||
ROC (Joel Greenblatt) % | -187.97 | |||||
ROCE % | -28.3 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.85 | |||||
PB Ratio | 3.52 | |||||
Price-to-Tangible-Book | 3.55 | |||||
EV-to-EBIT | -8.24 | |||||
EV-to-Forward-EBIT | -12.4 | |||||
EV-to-EBITDA | -9.36 | |||||
EV-to-Forward-EBITDA | -13.59 | |||||
EV-to-Revenue | 7.71 | |||||
EV-to-Forward-Revenue | 9.24 | |||||
EV-to-FCF | -10.69 | |||||
Price-to-Projected-FCF | 1.04 | |||||
Price-to-Net-Current-Asset-Value | 7.94 | |||||
Price-to-Net-Cash | 9.79 | |||||
Earnings Yield (Greenblatt) % | -12.15 | |||||
FCF Yield % | -7.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Moderna Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4,699.248 | ||
EPS (TTM) (€) | -14.591 | ||
Beta | 0.57 | ||
Volatility % | 55.96 | ||
14-Day RSI | 40.17 | ||
14-Day ATR (€) | 3.521518 | ||
20-Day SMA (€) | 115.014 | ||
12-1 Month Momentum % | 22.25 | ||
52-Week Range (€) | 64.46 - 154.76 | ||
Shares Outstanding (Mil) | 383.24 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Moderna Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Moderna Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Moderna Inc Frequently Asked Questions
What is Moderna Inc(WBO:MRNA)'s stock price today?
The current price of WBO:MRNA is €110.62. The 52 week high of WBO:MRNA is €154.76 and 52 week low is €64.46.
When is next earnings date of Moderna Inc(WBO:MRNA)?
The next earnings date of Moderna Inc(WBO:MRNA) is 2024-08-02 Est..
Does Moderna Inc(WBO:MRNA) pay dividends? If so, how much?
Moderna Inc(WBO:MRNA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |